Till death us do part? Postoperative statin discontinuation
Keywords:
postoperative statin discontinuationAbstract
With increasing frequency, anaesthesiologists are being presented with patients on chronic statin therapy or themselves prescribing statins to patients perioperatively. The reasons are twofold. Firstly, statin therapy is widely used for primary and secondary prevention of cardiovascular complications of atherosclerosis. Secondly, recent studies (supported by meta-analyses) provide relatively strong evidence that statins cost-effectively reduce the incidence of myocardial infarction after both non-cardiac and cardiac surgery. The available meta-analyses suggest that the risk reduction gained from perioperative statin therapy is clinically significant. Hindler and colleagues’ meta-analysis indicated that statin therapy was associated with 38% and 59% reductions in cardiac mortality after cardiac and vascular surgery respectively. Kapoor and colleagues estimated that statin users had a 30 to 42% lower postoperative incidence of cardiac death or acute coronary syndrome compared with patients in which no statin therapy was administered perioperatively.Downloads
Published
2008-02-08
Issue
Section
Guest Editorial
License
By submitting manuscripts to SAJAA, authors of original articles are assigning copyright to the SA Society of Anaesthesiologists. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAJAA for educational and research purposes without obtaining permission.
The work is licensed under a Creative Commons Attribution-Non-Commercial Works 4.0 South Africa License. The SAJAA does not hold itself responsible for statements made by the authors.